Published cases show cannabis can safely treat chemotherapy-induced nausea in children, and preclinical evidence suggests anti-cancer effects on pediatric tumors, but research remains extremely limited.
Pediatric oncologists, parents of children with cancer, medical cannabis researchers
Anti-cancer effects of cannabis known since 1975
What the researchers found
Published cases demonstrate the safety and efficacy of cannabis in children for pediatric epilepsy and chemotherapy-induced nausea and vomiting. Preclinical evidence shows cannabis has anti-cancer effects on pediatric cancer cell lines. However, the endocannabinoid system develops early in life, and data about prenatal cannabis exposure show negative outcomes.
Why it matters
Pediatric cancer treatments cause significant suffering, and options for managing side effects are limited. If cannabis can safely reduce nausea and potentially enhance cancer treatment in children, the implications are significant.
The numbers in context
Anti-cancer effects known since 1975; ECS components identified in 1990s; preclinical evidence in pediatric cancer cell lines
How the study worked
Narrative review examining published cases of cannabis use in pediatric populations, preclinical anti-cancer data on pediatric tumors, and what is known about ECS development and early-life cannabis exposure.
What this study cannot tell us
Nearly all cannabis anti-cancer research has been on adults. Preclinical evidence does not guarantee clinical efficacy. ECS role in development raises legitimate safety concerns.
How to read the evidence
Narrative review of case reports and preclinical data. No randomized controlled trials of cannabis as anti-cancer treatment in children.
When this study was published
Published in 2022
The bigger picture
The tension between caution about cannabis in developing brains and the reality of children suffering from cancer and its treatments demands careful research rather than blanket prohibition.
Questions still open
- At what age can cannabis-based treatments be considered safe for pediatric patients? Would low-THC, high-CBD formulations provide anti-cancer benefits without developmental concerns?
Common questions
Is cannabis safe for children with cancer?
Can cannabis fight pediatric cancer?
Read the original research
Medical Cannabis in Pediatric Oncology: Friend or Foe?
Pharmaceuticals (Basel, Switzerland), 15(3)
Citation
Malach, Megan; Kovalchuk, Igor; Kovalchuk, Olga. (2022). Medical Cannabis in Pediatric Oncology: Friend or Foe?. Pharmaceuticals (Basel, Switzerland), 15(3). https://doi.org/10.3390/ph15030359
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk